An actionable approach to improving diversity in clinical trial participation
Clinical trials are designed to test the safety and efficacy of a drug or device before it is approved for widespread use. To generate the most representative data, trial participants should represent the diverse population that will eventually use a new treatment.
Historically, the industry has failed to engage a number of minority communities in clinical research with certain populations experiencing significant under-representation. This is due in large part to the limited nature and delayed timing of the race and ethnicity data that sponsors receive.
StudyTeam’s Diversity Reporting provides aggregated reports of recruitment and enrollment metrics by race and ethnicity.
These insights allow sponsors to analyze these factors, help identify causes of underrepresentation of diverse populations in clinical trials, and support sponsors to take steps to improve diversity in current trials and better design future trials to be more inclusive.
OneStudyTeam, a member of the Reify Health family, provides the cloud-based software StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam is trusted by the largest global biopharmaceutical companies, used in over 5,000 research sites, and is available in over 100 countries. One platform, one team, one mission. That’s OneStudyTeam.
Play the video to hear how StudyTeam can help you speed up enrollment.